Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
26
2020
NIOSH Publishes Program Performance One-Pager for Nanotechnology Research Center Bergeson & Campbell, P.C.
Jun
26
2020
Court Bars CA Prop 65 Glyphosate Warning Requirement Keller and Heckman LLP
Jun
26
2020
Its High Time: Will Somebody Please Tell the Cannabis Industry about the TCPA Already? Troutman Amin, LLP
Jun
26
2020
California Federal Judge Enters Permanent Injunction Barring Enforcement of Prop. 65 Cancer Warning for Glyphosate as Unconstitutional Compelled Speech Keller and Heckman LLP
Jun
26
2020
CMS Proposes Rule to Pave the Way for Value-Based Drug Purchasing Mintz
Jun
26
2020
Market Entry and Real World Data – China’s Medical Device Industry K&L Gates
Jun
25
2020
Final Risk Evaluation for Methylene Chloride Is First Completed under Lautenberg Act Amendments Bergeson & Campbell, P.C.
Jun
25
2020
The Perpetuation of Class-Action Forum Shopping? Federal Circuits Address Whether Courts Need Personal Jurisdiction to Hear Nationwide Class Actions Greenberg Traurig, LLP
Jun
25
2020
US Trademark Office Waives/Refunds Fees for Reviving Applications and Registrations Abandoned Due to COVID-19 Dinsmore & Shohl LLP
Jun
25
2020
Band Together: Corporate and Cultural Convergence in Life Sciences M&A Mintz
Jun
25
2020
EPA Publishes Final Risk Evaluation for Methylene Chloride Bergeson & Campbell, P.C.
Jun
25
2020
EPA Orders OCCS, Inc. to Stop Sales of Unregistered Antimicrobial Disinfectant Products Bergeson & Campbell, P.C.
Jun
24
2020
New Florida Legislation Expands Pharmacist Scope of Practice Greenberg Traurig, LLP
Jun
24
2020
Citizen’s Petition Filed for FDA Pathway to Legally Market Supplements With CBD Faegre Drinker
Jun
24
2020
If you Handle PFAS, Your TRI May Be Different Next Year Beveridge & Diamond PC
Jun
24
2020
California Judge Dismisses Proposed Class Action Against Kellogg Vanilla Labeling Keller and Heckman LLP
Jun
23
2020
Ninth Circuit Rejects Plaintiffs’ Claims in Trio of ADA Disability Access Cases Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
23
2020
Update on FDA’s Comprehensive Regenerative Medicine Framework: Looming November 2020 Deadline Preceded by a Flurry of Letters from CBER and a New JAMA Editorial Mintz
Jun
23
2020
FDA Adds QR Code to Certain Food Export Certificates Keller and Heckman LLP
Jun
23
2020
FDA Issue Guidance on Manufacturing Drugs, APIs during COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Jun
22
2020
Trial Concludes in Challenge to EPA’s Denial of Fluoride Petition Bergeson & Campbell, P.C.
Jun
22
2020
Biogen v. Mylan: When Does a Specification Fail to Describe a Newly-Presented Claim? Schwegman, Lundberg & Woessner, P.A.
Jun
22
2020
New Citizens Petition Requests FDA Status for Hemp-Derived CBD in Dietary Supplements Keller and Heckman LLP
Jun
22
2020
Temporary Food Labeling Policies in Light of the COVID-19 Pandemic Polsinelli PC
Jun
19
2020
Transatlantic Trade: US and European Trade Talk Update – June 19, 2020 Squire Patton Boggs (US) LLP
Jun
19
2020
California Employers Face Broader Recording and Reporting Obligations for COVID-19 Illnesses Beveridge & Diamond PC
Jun
19
2020
Not Today Corona: EEOC Prohibits Testing Employees for Antibodies Sheppard, Mullin, Richter & Hampton LLP
Jun
19
2020
FDA’s Revocation of the Hydroxychloroquine and Chloroquine EUA May Test the Limits of PREP Act Immunity Faegre Drinker
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins